
### [MONDO:0017675](http://purl.obolibrary.org/obo/MONDO_0017675)
**Label:** punctate palmoplantar keratoderma

**Subclasses:** [MONDO:0017676](http://purl.obolibrary.org/obo/MONDO_0017676) (marginal papular palmoplantar keratoderma), [MONDO:0017679](http://purl.obolibrary.org/obo/MONDO_0017679) (autosomal dominant disease associated with punctate palmoplantar keratoderma as a major feature), [MONDO:0017678](http://purl.obolibrary.org/obo/MONDO_0017678) (disease with punctate palmoplantar keratoderma as a major feature), [MONDO:0017680](http://purl.obolibrary.org/obo/MONDO_0017680) (autosomal recessive disease associated with punctate palmoplantar keratoderma as a major feature), [MONDO:0019332](http://purl.obolibrary.org/obo/MONDO_0019332) (punctate palmoplantar keratoderma type 1), [MONDO:0016518](http://purl.obolibrary.org/obo/MONDO_0016518) (isolated punctate palmoplantar keratoderma), 

**Corr. equiv. classes:** [Orphanet:79501](http://www.orpha.net/ORDO/Orphanet_79501), [Orphanet:308031](http://www.orpha.net/ORDO/Orphanet_308031), [Orphanet:308041](http://www.orpha.net/ORDO/Orphanet_308041), [Orphanet:308023](http://www.orpha.net/ORDO/Orphanet_308023), [Orphanet:2338](http://www.orpha.net/ORDO/Orphanet_2338), [Orphanet:307995](http://www.orpha.net/ORDO/Orphanet_307995), 

**Class expressions from DL-Learner:**

- [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 66.67%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) 66.67%
- [HP:0001597](http://purl.obolibrary.org/obo/HP_0001597) (Abnormality of the nail) and [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) 66.67%
- [HP:0000982](http://purl.obolibrary.org/obo/HP_0000982) (Palmoplantar keratoderma) and [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) 66.67%
- [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and [HP:0100013](http://purl.obolibrary.org/obo/HP_0100013) (Neoplasm of the breast) 66.67%
- [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 66.67%
- [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 66.67%
- [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 66.67%
- [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 66.67%
- [HP:0003002](http://purl.obolibrary.org/obo/HP_0003002) (Breast carcinoma) and [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 66.67%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0100013](http://purl.obolibrary.org/obo/HP_0100013) (Neoplasm of the breast) 66.67%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 66.67%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) 66.67%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology) 66.67%
- [HP:0002665](http://purl.obolibrary.org/obo/HP_0002665) (Lymphoma) and [HP:0003003](http://purl.obolibrary.org/obo/HP_0003003) (Colon cancer) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 66.67%


